Imidazole → 4-{[tert-Butyl(dimethyl)silyl]oxy}-2,3-dihydro-1H-inden-1-one
Reaction equation
[OH:1][C:2]1[CH:10]=[CH:9][CH:8]=[C:7]2[C:3]=1[CH2:4][CH2:5][C:6]2=[O:11].N1C=CN=C1.[Si:17](Cl)([C:20]([CH3:23])([CH3:22])[CH3:21])([CH3:19])[CH3:18]>C(Cl)Cl.CCOC(C)=O>[C:20]([Si:17]([CH3:19])([CH3:18])[O:1][C:2]1[CH:10]=[CH:9][CH:8]=[C:7]2[C:3]=1[CH2:4][CH2:5][C:6]2=[O:11])([CH3:23])([CH3:22])[CH3:21]Participants
6
Procedure
To a solution of 4-hydroxy-indan-1-one (1.0 g, 6.75 mmol) in CH2Cl2 (20 mL) was added imidazole (690 mg, 10.12 mmol). The mixture was stirred for 5 minutes, to which was added portionwise tert-butyldimethylsilyl chloride (1.05 g, 5.31 mmol). The mixture was stirred for 3 hours at room temperature and was diluted with EtOAc. The organic layer was washed with 1N HCl, water and brine, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified by column chromatography to give 4-(tert-butyl-dimethyl-silanyloxy)-indan-1-one (1600 mg, 90%).
Workup
- stirringThe mixture was stirred for 3 hours at room temperature
- washThe organic layer was washed with 1N HCl, water and brine
- dry with materialdried over anhydrous magnesium sulfate
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- customThe crude residue was purified by column chromatography
Sources & evidence
- ORD record
- ord-28290f292fa84c1382bfe340ae71aec1
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08691855B2
Reaction notes
Loading…